Thoracic medical oncologist at the Dana-Farber Cancer Institute; Professor at Harvard Medical School; Director of the Lowe Center for Thoracic Oncology; Director of the Belfer Center for Applied Cancer Science
Pasi Jänne, M.D., Ph.D.’s main research interests include studying the therapeutic relevance of oncogenic alterations in lung cancer. Dr. Jänne was one of the co-discoverers of epidermal growth factor receptor (EGFR) mutations and has led the development of therapeutic strategies for patients with EGFR mutant lung cancer.
Dr. Jänne earned a medical doctor degree and doctor of philosophy degree at the University of Pennsylvania in Philadelphia in 1996. He completed postgraduate training in internal medicine at Brigham and Women’s Hospital and in medical oncology at Dana-Farber Cancer Institute in Boston in 2001.